Amrita Chattopadhyay

Dr. Amrita Chattopadhyay


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Open access
PDF file
JJJyh-Ming Jimmy Juang
Jyh-Ming Jimmy Juang
YLYen Bin Liu
Yen Bin Liu
CCChing-Yu Julius Chen
Ching-Yu Julius Chen
QYQi-You Yu
Qi-You Yu
ACAmrita Chattopadhyay
Amrita Chattopadhyay
MAMichael J. Ackerman
Michael J. Ackerman
Background: Brugada syndrome (BrS) is an oligogenic arrhythmic disease with increased risk of sudden cardiac arrest. Several BrS or ECG traits-related single-nucleotide polymorphisms (SNPs) were identified through previous genome-wide association studies in white patients. We aimed to validate these SNPs in BrS patients in the Taiwanese population, assessing the cumulative effect of risk alleles and the BrS-polygenic risk score in predicting cardiac events. Methods: We genotyped 190 unrelated BrS patients using the TWB Array, and Taiwan Biobank was used as controls. SNPs not included in the array were imputed by IMPUTE2. Cox proportional hazards model was used to evaluate the associations between each particular SNP, the collective BrS-polygenic risk score, and clinical outcomes. Results: Of the 88 previously reported SNPs, 22 were validated in Taiwanese BrS patients ( P <0.05). Of the 22 SNPs, 2 (rs10428132 and rs9388451) were linked with susceptibility to BrS, 10 were SNPs previously reaching genome-wide significance, and 10 were SNPs associated with ECG traits. For the 3 most commonly reported SNPs, disease risk increased consistently with the number of risk alleles (odds ratio, 3.54; P trend =1.38×10 −9 for 5 risk alleles versus 1). Similar patterns were observed in both SCN5A mutation+ (odds ratio, 3.66; P trend =0.049) and SCN5A mutation− (odds ratio, 3.75; P trend =8.54×10 −9 ) subgroups. Furthermore, BrS patients without SCN5A mutations had more risk alleles than BrS patients with SCN5A mutations regardless of the range of polygenic risk scores. Three SNPs (rs4687718, rs7784776, and rs2968863) showed significant associations with the composite outcome (sudden cardiac arrest plus syncope, hazard ratio, 2.13, 1.48, and 0.41; P =0.02, 0.006, and 0.008, respectively). Conclusions: Our findings suggested that some SNPs associated with BrS or ECG traits exist across multiple populations. The cumulative risk of the BrS-related SNPs is similar to that in white BrS patients, but it appears to correlate with the absence of SCN5A mutations.

31 July 2023 in GeroScience
Verified
Journal Article
Closed access
PDF file
WTWatson Hua-Sheng Tseng
Watson Hua-Sheng Tseng
ACAmrita Chattopadhyay
Amrita Chattopadhyay
NPNam Nhut Phan
Nam Nhut Phan
ECEric Y. Chuang
Eric Y. Chuang
Oscar Kuang-Sheng LeeOscar Kuang-Sheng Lee
Oscar Kuang-Sheng Lee

11 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CWChia-Hsin Wu
Chia-Hsin Wu
HYHsien-Tang Yeh
Hsien-Tang Yeh
CHChia-Shan Hsieh
Chia-Shan Hsieh
CHChi-Cheng Huang
Chi-Cheng Huang
ACAmrita Chattopadhyay
Amrita Chattopadhyay
ECEric Y. Chuang
Eric Y. Chuang
The evolutionary trajectories that drive clinical and therapeutic consequences in localized breast cancers (BCs) with ipsilateral breast tumor relapse (IBTR) remain largely unknown. Analyses of longitudinal paired whole-exome sequencing data from 10 localized BC patients with IBTR reveal that, compared to primary breast tumors, homologous recombination (HR) deficiency, inactivation of the HR pathway, chromosomal instability, and somatic driver mutations are more frequent. Furthermore, three major models of evolution in IBTR are summarized, through which relative contributions of mutational signatures shift, and the subclonal diversity expansions are shown. Optimal treatment regimens are suggested by the clinically relevant molecular features, such as HR deficiency (20%) or specific alterations (30%) with sensitivity to available FDA-approved drugs. Finally, a rationale for the development of the therapeutic management framework is provided. This study sheds light on the complicated evolution patterns in IBTR and has significant clinical implications for future improvement of treatment decisions.

26 February 2025 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
MHMing-Shun Hsieh
Ming-Shun Hsieh
PWPei-Hsuan Wu
Pei-Hsuan Wu
KCKuan-Chih Chiu
Kuan-Chih Chiu
SLShu-Hui Liao
Shu-Hui Liao
CCChe-Shao Chen
Che-Shao Chen
TLTzu-Pin Lu
Tzu-Pin Lu
Background: Sepsis is characterized by organ dysfunction as a response to infection and is one of the leading causes of mortality and loss of health. The heterogeneous nature of sepsis, along with ethnic differences in susceptibility, challenges a thorough understanding of its etiology. This study aimed to propose prediction models by leveraging genetic-risk scores and clinical variables that can assist in risk stratification of patients. Methods: A total of 1,403 patients from Taiwan, diagnosed with sepsis, were utilized. Genome-wide survival analysis was conducted, with death within 28 days from sepsis onset, as the primary event to report significantly associated SNPs. A polygenic risk score (PRS-sepsis) was constructed via clumping and thresholding method which was added to clinical-only models to generate better performing prognostic models for identifying high-risk patients. Kaplan–Meier analysis was conducted using PRS-sepsis. Results: A total of five single-nucleotide-polymorphisms (SNPs) reached genome-wide significance (p < 5e-8), and 86 SNPs reached suggestive significance (p < 1e-5). The prognostic model using PRS-sepsis showed significantly improved performance with c-index [confidence interval (CI)] of 0.79 [0.62–0.96] and area under receiver operating characteristic curve (AUROC) [CI] of 0.78 [0.75–0.80], in comparison to clinical-only prognostic models (c-index [CI] = 0.63 [0.45– 0.81], AUROC [CI] = 0.61 [0.58–0.64]). The ethnic specificity was established for our proposed models by comparing it with models generated using significant SNPs from prior European studies (c-index [CI] = 0.63 [0.42–0.85], AUROC [CI] = 0.60 [0.58–0.63]). Kaplan–Meier plots showed that patient groups with higher PRSs have inferior survival probability compared to those with lower PRSs. Conclusions: This study proposed genetic-risk models specific for Taiwanese populations that outperformed clinical-only models. Also it established a strong racial-effect on the underlying genetics of sepsis-related mortality. The model can potentially be used in real clinical setting for deciding precise treatment courses for patients at high-risk thereby reducing the possibility of worse outcomes.

6 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MHMing-Shun Hsieh
Ming-Shun Hsieh
ACAmrita Chattopadhyay
Amrita Chattopadhyay
TLTzu-Pin Lu
Tzu-Pin Lu
SLShu-Hui Liao
Shu-Hui Liao
CCChia Ming Chang
Chia Ming Chang
CHChorng-Kuang How
Chorng-Kuang How
End-stage renal disease (ESRD) patients on long-term hemodialysis (HD) have an elevated risk of sudden cardiac death. This study hypothesizes, for the first time, that these patients have a higher odds of return of spontaneous circulation (ROSC) and subsequent better hospital-outcomes, post out-of-hospital cardiac arrest (OHCA), as opposed to non-ESRD patients. A national database from Taiwan was utilized, in which 101,876 ESRD patients undergoing HD and propensity score-matched non-ESRD patients were used to conduct two analyses: (i) Cox-proportional-hazards-regression for OHCA incidence and (ii) logistic-regression analysis of attaining ROSC after OHCA, both for ESRD patients in comparison to non-ESRD patients. Kaplan-Meier analyses were conducted to determine the difference of survival rates after ROSC between the two cohorts. ESRD patients were found to be at a higher risk of OHCA (adjusted-HR = 2.11, 95% CI: (1.89–2.36), p < 0.001); however, they were at higher odds of attaining ROSC (adjusted-OR = 2.47, 95% CI: 1.90–3.21, p < 0.001), as opposed to non-ESRDs. Further, Kaplan-Meier analysis demonstrated ESRD patients with a better 30-day hospital survival rate than non-ESRD patients. Although ESRD patients had a higher risk of OHCA, they demonstrated higher possibility of ROSC and a better short-term hospital outcome than non-ESRDs. Chronic toxin tolerance and the training of vascular-compliance during regular HD may be possible explanations for better outcomes in ESRD patients.

8 April 2026 in GeroScience
Verified
Journal Article
Open access
MHMing-Shun Hsieh
Ming-Shun Hsieh
SYShu-Min Yang
Shu-Min Yang
SLShu-Hui Liao
Shu-Hui Liao
CGChayanika Goswami
Chayanika Goswami
PWPei-Hsuan Wu
Pei-Hsuan Wu
ACAmrita Chattopadhyay
Amrita Chattopadhyay
Human longevity arises from complex genetic and environmental interactions, yet the genetic basis of survival to extreme old age remains underexplored in Asian populations. We performed genome-wide association studies (GWAS) in a Taiwanese cohort, defining survival thresholds at ≥ 85, ≥ 90, and ≥ 95 years, and validated significant loci in an independent cohort. Multiple loci, including ZNF806, NUAK1, TANC1, SLC22A3, PTPRD, and PCSK2, were associated with longevity, of which 14 replicated with consistent effect directions (82% concordance). Allele frequencies aligned with East Asian references but diverged from prior Han Chinese studies, reflecting sub-ethnic variation. Polygenic risk scores (PRSs) alone showed limited predictive ability but provided statistically significant incremental improvement when integrated with clinical covariates. In the external validation cohort, adding PRS modestly improved model discrimination (AUC from 0.900 to 0.904 for ≥ 85 years and from 0.893 to 0.912 for ≥ 90 years) and yielded the largest improvement in the ≥ 95 group (AUC from 0.913 to 0.956; DeLong P < 10⁻⁸), with corresponding gains in reclassification metrics. These findings suggested that while clinical factors remained the primary predictors of survival, genetic risk captured by PRS contributed additional information, particularly at extreme longevity thresholds. Together, the results highlighted an age-dependent genetic architecture enriched for neural, cardio-metabolic, and stress-response pathways and supported the use of genetics-informed models as complementary tools for precision aging research in Taiwanese populations.